Barclays »

Neuropace shares owned by Barclays

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $147k 14k 10.55
2023-09-30 $105k 11k 9.69
2023-06-30 $1.0k 118 8.47
2023-03-31 $1.0k 118 8.47
2022-12-31 $0 118 0.00
2022-09-30 $12k 3.2k 3.73
2022-06-30 $17k 3.4k 5.00
2022-03-31 $38k 4.6k 8.35